This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Australian Pharmaceutical Industries Limited completed the acquisition of SILK Laser Australia Limited from Wilson Asset Management (International) Pty Limited and others. CI
Australian Pharmaceutical Industries Limited completed the acquisition of InstantScripts Pty Ltd from Bailador Technology Investments Limited and others. CI
Australian Pharmaceutical Industries Limited agreed to acquire InstantScripts Pty Ltd from Bailador Technology Investments Limited and others for approximately AUD 140 million. CI
Australian Pharmaceutical Industries Limited terminated the process deed to acquire SILK Laser Australia Limited from Wilson Asset Management (International) Pty Limited and others CI
Australian Pharmaceutical Industries Limited made a offer to acquire SILK Laser Australia Limited from Wilson Asset Management (International) Pty Limited and others for approximately AUD 170 million. CI
Biome Australia Limited Signs Material Distribution Agreement with Australian Pharmaceutical Industries CI
Wesfarmers Completes Acquisition of Australian Pharmaceutical Industries MT
Wesfarmers Limited completed the acquisition of Australian Pharmaceutical Industries Limited from Washington H. Soul Pattinson and Company Limited and others. CI
Australian Pharmaceutical Industries Limited(ASX:API) dropped from S&P Global BMI Index CI
Australian Pharmaceutical Industries Limited(ASX:API) dropped from S&P/ASX 300 Index CI
Australian Pharmaceutical Industries Limited(ASX:API) dropped from S&P/ASX All Ordinaries Index CI
Australian Pharmaceutical Industries Limited(ASX:API) dropped from S&P/ASX Small Ordinaries Index CI
Wesfarmers Secures Court Approval to Acquire Australian Pharmaceutical Industries MT
Australian Pharmaceutical Industries Limited Announces Special Dividend Within the Financial Year 2022, Payment Date Is March 29, 2022 CI
Competition Watchdog Clears Wesfarmers' Acquisition of Australian Pharmaceutical Industries MT
Transcript : Australian Pharmaceutical Industries Limited - Shareholder/Analyst Call
Australia's Wesfarmers flags lower first-half profit hurt by coronavirus curbs RE
Australian Shares Recoup Some Losses on Bargain Hunting MT
Financials, energy stocks lead rebound in Australian shares RE
Woolworths Withdraws $609 Million Takeover Proposal for Australian Pharmaceutical Industries MT
Woolworths Withdraws its Proposal to Acquire Australian Pharmaceutical CI
Australian shares rebound as financials gain, James Hardie sinks RE
Wesfarmers to buy Australia's API for $547 mln after Woolworths backs out RE
API Acquisition by Wesfarmers on Track After Woolworths Withdraws DJ
Woolworths Group Limited cancelled the acquisition of Australian Pharmaceutical Industries Limited from Wesfarmers Limited and others. CI
Chart Australian Pharmaceutical Industries Limited
More charts
Australian Pharmaceutical Industries Limited is an Australia-based pharmaceutical distributor, and health and beauty retailer company. The Company's segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The Company's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. API Stock
  4. News Australian Pharmaceutical Industries Limited
  5. Australian Pharmaceutical Industries Receives Non-Binding Takeover Bid from Woolworths